honor-k8凯发

honor-k8凯发

en

en

k8凯发-凯发k8国际

中文繁体

  • our company

    our company

    shanghai fosun pharmaceutical (group) co., ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in china

    about company

    leadership

    honor

    brand culture

    member companies

    founded in 1994, shanghai fosun pharmaceutical (group) co., ltd. ("fosun pharma"; stock code: 600196. sh, 02196. hk) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in china. fosun pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. as a shareholder of sinopharm co., ltd., fosun pharma expands its areas in the pharmaceutical distribution and retail business.
  • our business

    our business

    shanghai fosun pharmaceutical (group) co., ltd. (fosun pharma) directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. as a shareholder of sinopharm group co., ltd., fosun pharma expands its areas in the pharmaceutical distribution and retail business.

    pharmaceutical manufacturing

    vaccines

    medical devices

    medical diagnosis

    healthcare services

    pharmaceutical distribution and retail

    fosun pharma is patient-centered and clinical needs-oriented. the company enriches its innovative product pipeline through diversified and multi-level cooperation models such as independent research and development, cooperative development, license-in, and in-depth incubation. fosun pharma has formed technological platforms for innovative small molecule drugs, antibody drugs, and cell therapy with a focus on key disease areas including oncology and immunomodulation, metabolism and digestive system, and central nervous system. fosun pharma also vigorously explores cutting-edge technologies, such as rna, oncolytic viruses, gene therapy and protac, to enhance its innovation capabilities.
  • r&d

    r&d

    shanghai fosun pharmaceutical (group) co., ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in china.

    global r&d center

    r&d pipeline

    innovation platform

    clinical development

    r&d news

    through in-house research and development, co-development, in-licensing, incubation, and other diverse and multi-level cooperation models, fosun pharma, patient-centered and oriented by clinical needs, has enriched its innovative product lines. it builds technological platforms for small molecule innovator drugs, antibody drugs, and cell therapy in major areas including oncology and immunomodulation, metabolism and digestive system, and central nervous system. it also vigorously explores cutting-edge technologies, such as rna, oncolytic viruses, gene therapy and protac, to enhance its innovation.
  • sustainability

    sustainability

    in pursuit of sustainable development of talents and products is the social responsibility concept of fosun pharma.

    social responsibility strategy

    special fund for fosun pharma health care initiative

    social welfare

    csr news

    social responsibility report download

    environmental, social and governance report download

    fosun pharma has incorporated the sustainable development strategy into its overall development, and established a sound sustainable development management system. it has set up a corporate social responsibility management committee and an environmental, social and governance (esg) committee under the board of directors to promote the sustainable development of the group. moreover, a sound communication mechanism between stakeholders has been established to continuously improve their satisfaction, maintain its competitiveness in sustainable development, and lead the development of the industry.
  • investor relations

    investor relations

    shanghai fosun pharmaceutical (group) co., ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in china.

    announcements

    corporate governance

    financial report

    investor presentation materials

    faqs

    investor contact

    founded in 1994, shanghai fosun pharmaceutical (group) co., ltd. ("fosun pharma"; stock code: 600196.sh, 02196.hk) is a global innovation-driven group in the pharmaceutical and healthcare industry based in china. fosun pharma strategically operates businesses in the pharmaceutical and healthcare industry, including pharmaceutical manufacturing, medical devices and medical diagnosis, and healthcare services. through equity participation in sinopharm co., ltd., fosun pharma's business extends to pharmaceutical distribution and retail.
  • news

    news

    shanghai fosun pharmaceutical (group) co., ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in china.

    press release

    member companies news

    media resources

    media contact

    founded in 1994, shanghai fosun pharmaceutical (group) co., ltd. ("fosun pharma"; stock code: 600196. sh, 02196. hk) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in china. fosun pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. as a shareholder of sinopharm co., ltd., fosun pharma expands its areas in the pharmaceutical distribution and retail business.
  • careers

    careers

    some top talent with strong entrepreneurship gathers here with us.

    talent concept

    incentives

    life at fosun pharma

    we are looking for people that recognize and practice our cultural values, and can learn fast to create continuous value; possess profound professional knowledge of the industry, a wide vision of different regions, and global-level expertise in a certain field. we will also be committed to cultivating international top talent with outstanding performance and great potential.
  • 2022-03-22

    the corporate social responsibility report of fosun pharma has been honored with the five-star report (excellent) by the china corporate social responsibility report rating expert committee for two consecutive years

    china corporate social responsibility report rating expert committee

  • 2021-08-26

    fosun pharma has been honored with the china company award of hong kong business awards for 2021

    south china morning post

  • 2021-07-21

    fosun pharma ranked 6th in the 2020 top 100 chinese chemical and pharmaceutical enterprises

    china medical and health industry symbiosis conference

  • rankings and awards

    1. ranked 7th in 2020 top 100 pharmaceutical enterprises in china

      ministry of industry and information technology of the people's republic of china, china national pharmaceutical industry information center

    2. awarded the enterprise with excellent innovation of the enterprise management award for the pharmaceutical industry in the 13th five-year plan

      china pharmaceutical enterprises association, china nonprescription medicines association

    3. 2021 top 20 listed chinese pharmaceutical companies

      china pharmaceutical enterprises association

    4. awarded guangdong-hong kong-macau-bay area top 100 heritage enterprises award

      guangdong-hong kong-macao-bay area economic and trade association

    5. 2021 china's top 500 brands

      asia brand

    6. ranked 6th in 2020 top 100 chinese chemical and pharmaceutical enterprises

      www.menet.com.cn

    7. 2021 china biomedical industry chain innovation billboard
      2021 excellent pipelines (top 3)
      2021 golden horse award for innovative enterprises with top r&d strengths
      2021 golden horse award for best business development

      progress in pharmaceutical sciences

    8. 2021 top 100 chinese pharmaceutical innovation enterprises

      healthcare executive

    9. awarded the china company award of hong kong business awards for 2021

      south china morning post

    10. 2021 influential pharmaceutical industry enterprise

      med.sina.com

    11. awarded the 2021 mainboard "star" company in the 16th selection of chinese listed companies with competitiveness and credibility

      chinese securities journal

  • social responsibility

    1. the corporate social responsibility report of fosun pharma has been honored with the five-star report (excellent) by the china corporate social responsibility report rating expert committee for two consecutive years

      china corporate social responsibility report rating expert committee

    2. shanghai corporate social responsibility report releases outstanding enterprise

      shanghai federation of economic organizations, shanghai federation of industrial economics

    3. 2020 epidemic prevention and control contribution award

      chinese society of clinical oncology

    4. 2020 china corporate social responsibility contribution award

      shanghai charity foundation

    5. china top esg 500

      sina finance esg rating center, cctv-1 "the growing of the great brand" program

    6. outstanding company in technological innovation award for corporate social responsibility promotion project in “2021 china benefit corporation”

      tencent news

    7. annual outstanding csr award of the 10th “goldenwis” award of jrj navigation china

      jrj.com

    8. awarded evergreen award in 2021 goldenbee excellent corporate

      social responsibility report china sustainability tribune, goldenbee think tank

  • senior executive

    1. wu yifang, chairman and ceo of fosun pharma, was awarded the 2021 shanghai may day labor medal

      shanghai municipal federation of trade unions

    2. wu yifang, chairman and ceo of fosun pharma, was awarded the
      "2019-2020 shanghai outstanding entrepreneur"

      shanghai enterprises association, shanghai entrepreneur association

    3. wu yifang, chairman and ceo of fosun pharma, was awarded outstanding figure at the first china otc conference

      china nonprescription medicines association

    4. wu yifang, chairman and ceo of fosun pharma, was awarded the figure of the year 2021 golden leaf award

      china medical pharmaceutical material association

    5. wu yifang, chairman and ceo of fosun pharma, was selected for the 2021 forbes china best ceos list

      forbes china

    6. wu yifang, chairman and ceo of fosun pharma, was awarded top 10 pharmaceutical industry figures of the 13th healthy china forum

      people's daily health app, health times of people's daily

    7. wu yifang, chairman and ceo of fosun pharma, was awarded the most influential entrepreneur in 2021

      sina finance

    8. dr. hui aimin, executive president, president of global r&d center, chief medical officer of fosun pharma, was awarded the fourth international translational medical cooperation award

      shanghai guangci translational medical research foundation, national facility for translational medicine association

    9. dr. hui aimin, executive president, president of global r&d center, chief medical officer of fosun pharma, was named one of the 2020 top 10 pharmaceutical innovation scientists

      securities times

  • corporate culture

    1. 2019-2020 shanghai model unit

    2. cpc shanghai municipal committee, shanghai municipal people's government

网站地图